VectivBio Holding AG

Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares

Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio

Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround

VECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG - VECT

VECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG - VECT

Why Shares of VectivBio Holding Are Up Today

VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion

VECT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of VectivBio Holding AG Is Fair to Shareholders

Ironwood Pharmaceuticals to Acquire VectivBio for About $1 Billion

Ironwood Pharmaceuticals to acquire Swiss biotech VectivBio in deal valued at about $1 billion

Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

VectivBio: Swiss Company With Excellent Data, Upcoming Catalysts

VectivBio to Present at the 2022 Jefferies London Healthcare Conference

VectivBio Announces Date of Extraordinary General Meeting of Shareholders

VectivBio Holding AG (VECT) CEO Luca Santarelli on Q4 2021 Results - Earnings Call Transcript

VectivBio to Present at the SVB Leerink 11th Annual Global Healthcare Conference

6 Underperforming IPO Stocks To Buy On The Dip

VectivBio to Present at the Credit Suisse 30th Annual Healthcare Conference

VectivBio Announces Closing of Comet Therapeutics Acquisition

VectivBio Announces Upcoming Investor Events